EQUASENS: results of the votes on the resolutions submitted to the ordinary annual shareholders' meeting of 29 june 2023
Villers-lès-Nancy, 5 July 2023 - 6:00 p.m. (CET)
PRESS RELEASE
RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED
TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING
OF 29 JUNE 2023
Number of shares comprising the share capital: 15,174,125
Number of shares with voting rights: 15,032,834
Number of shares with voting rights possessed by shareholders presents or represented or having voted by mail: 13,046,120
That means a quorum of 86.78% of the 15,032,834 shares with voting rights: the Ordinary Annual General Meeting was able to deliberate.
The Ordinary Annual General Meeting was held on Thursday, 29 June 2023 at 5:30 p.m. at the Company’s headquarters and approved the separate parent company and consolidated financial statements for the 2022 financial year. The results of the votes on the resolutions proposed at this meeting by the Board of Directors were as follows:
| Resolutions | Results of the votes |
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by (*):
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
| Resolution adopted by:
|
(*) After deduction of excluded voting rights
Financial Calendar:
- Publication of H1 2023 Revenue: 3 August 2023, after French market closure.
About
Founded more than 35 years ago, Equasens Group, which now has more than 1,200 employees in Europe, is the leading publisher of software solutions for the healthcare industry in terms of the diversity of its business applications and market share.
Equasens Group’s specialised business applications facilitate the day-to-day work of healthcare professionals and their teams, working in private practice, collaborative medical structures or healthcare establishments. The Group also provides comprehensive support to healthcare professionals in the transformation of their profession by developing electronic equipment, digital solutions and healthcare robotics, as well as financing and training adapted to their specific needs.
And reflecting the spirit of its tagline " technology for a more human experience", the Group is a leading provider of interoperability solutions that improve coordination between healthcare professionals, their communications and data exchange resulting in better patient care and a more efficient healthcare system.
Listed on Euronext Paris™ - Compartment A
Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable
Included in the Euronext Tech Leaders segment and the European Rising Tech label
Eligible for the Deferred Settlement Service (“Service à Règlement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME)
ISIN: FR 0012882389 – Ticker Code: EQS
Get all the news about the Equasens Group and on
CONTACTS
Analyst and Investor Relations:
Chief Administrative and Financial Officer: Frédérique SCHMIDT
Tel. +33 (0)3 83 15 90 67 -
Media Relations:
FIN’EXTENSO - Isabelle APRILE
Tel. +33 (0)6 17 38 61 78 -
Attachment
